SCHEMBL6300415

SCHEMBL6300415

COc1cccc(-c2[nH]c3ccc(OC)cc3c(=O)c2C(=O)O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.56
TUBB4A P04350 1/20 0.54
TUBB P07437 1/20 0.54
TUBA3C P0DPH7 1/20 0.54
TUBA1B P68363 1/20 0.54
TUBA4A P68366 1/20 0.54
TUBB4B P68371 1/20 0.54
TUBB3 Q13509 1/20 0.54
TUBB2A Q13885 1/20 0.54
TUBB8 Q3ZCM7 1/20 0.54
TUBA3E Q6PEY2 1/20 0.54
TUBA1A Q71U36 1/20 0.54
TUBA1C Q9BQE3 1/20 0.54
TUBB6 Q9BUF5 1/20 0.54
TUBB2B Q9BVA1 1/20 0.54
TUBB1 Q9H4B7 1/20 0.54
SERPINE1 P05121 1/20 0.53
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300691 0.92 TUBB4A (0.62) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6294920 0.91 TUBB4A (0.52) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6296013 0.91 ALDH1A1 (0.60) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6294965 0.91 SERPINE1 (0.49) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6294655 0.91 ABCG2 (0.51) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6300606 0.85 KDM4E (0.56) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6295747 0.84 ABCG2 (0.51) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6300802 0.81 ABCG2 (0.54) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL6300675 0.81 ABCG2 (0.54) ABCG2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7455829 0.79 TUBB4A (0.57) ABCG2TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK ABCG2 26/4885TUBB4A 268/4885TUBB 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.